期刊文献+

体外膜肺氧合治疗用于心肺复苏的临床研究 被引量:9

Clinical experience of extracorporeal membrane oxygenation resuscitation in cardiac arrest patients
下载PDF
导出
摘要 目的总结体外膜肺氧合(ECMO)治疗对于常规心肺复苏(CPR)困难患者的临床治疗经验。方法自2005 -09~2006-05我院进行ECMO治疗37例患者,其中11例心脏骤停后实施电除颤和心脏按压等CPR措施无效或自主循环恢复后持续低心排而行ECMO循环辅助。结果8例顺利停机,6例存活恢复出院,其中2例行心脏移植后康复出院。3例不能顺利撤机者在ECMO辅助期间由于循环功能恶化,最终因多器官功能衰竭死亡。顺利撤机和存活出院的患者治疗前乳酸水平较低,ECMO治疗后乳酸清除率较快(P<0.05)。ECMO期间出现的并发症包括出血、神经精神系统异常、肢体缺血坏死和多脏器功能不全。4例患者因膜肺出现血浆渗漏而更换膜肺。结论ECMO可为危重心脏病患者心脏骤停后复苏困难时提供心肺功能支持,提高危重心脏病患者CPR的存活率。CPR后动脉血乳酸值和ECMO治疗后乳酸清除率可以预测患者预后。 Objective To sum up clinical experience of extracorporeal membrane oxygenation (ECMO) treatment for the patients with cardiopulmonary resuscitation( CPR ). Methods 37 cases who underwent ECMO treatment from Sep. 2005 to May 2006 in our hospital were studied retrospectively. 11 cases with cardiac arrest accepted CPR before ECMO, and we reviewed the data of 11 CPR patients. Candidates for ECMO resuscitation were the patients who didn't response to CPR or returned to spontaneous circulation with persistent heart failure and needed ECMO support urgently after CPR. Results 8 eases were successfully weaned from ECMO. 6 cases survived and discharged at last , but 2 cases received heart transplantation. In the patients weaned successfully and survived, the blood lactate level was lower before ECMO treatment, and the lactate clearance rate was quicker. The complications during ECMO included bleeding, renal failure, neurological complications, infection and MODS. Conclusion ECMO can improve survival rate and the prognosis of patients with critical heart disease. The lactate level after CPR and the clearance rate after ECMO support can predict the prognosis of patients.
出处 《中国急救医学》 CAS CSCD 北大核心 2006年第12期911-914,共4页 Chinese Journal of Critical Care Medicine
基金 北京市科技计划项目(No.H030930020130)
关键词 体外膜肺氧合 心脏骤停 心肺复苏 Extracorporeal membrane oxygenation (ECMO) Cardiac arrest Cardiopulmonary resuscitation(CPR)
  • 相关文献

参考文献9

  • 1KO Wen-je,CHOU Yueh-ting.外科危重患者的体外膜肺氧合支持[J].中国体外循环杂志,2005,3(4):226-229. 被引量:10
  • 2Yih-Sharng Chen,Anne Chao,Hsi-Yu Yu,et al.Analysis and results of prolonged resuscitation in cardiac arrest patients rescued by extracorporeal membrane oxygenation[J].J Am Coll Cardiol,2003,41 (2):197-203. 被引量:1
  • 3Gueugniaud PY,Mds P,Goldstein P,et al.A comparison of repeated high doses and repeated standard doses of epinephrine for cardiac arrest outside the hospita1[J].N Engl J Med,1998,339 (22):1595-1601. 被引量:1
  • 4Martin GB,Rivers EP,Paradise NA,et al.Emergency department cardiopulmonary bypass in the treatment of human cardiac arrest[J].Chest,1998,113(3):743-751. 被引量:1
  • 5Tisherman SA,Valdevelde K,Safar P.Future directions for resuscitation research.Ultra-advanced life support[J].Resuscitation,1997,34(3):281-293. 被引量:1
  • 6Landry FJ,Parker JM,Phillips YY,et al.Outcome of cardiopulmonary resuscitation in the intensive care setting[J].Arch Intern Med,1992,152(11):2305-2308. 被引量:1
  • 7Schultz SC,Cullinane DC,Pasquale MD,et al.Predicting in-hospital mortality during cardiopulmonary resuscitation[J].Resuscitation,1996,33(1):13-17. 被引量:1
  • 8陈利民,余剑波.围手术期乳酸监测的临床意义[J].临床麻醉学杂志,2004,20(10):638-639. 被引量:18
  • 9Kasimjan V,Simmons Ⅰ,King J,et al.Technique to prevent limb ischemia during peripheral cannulation for extracorporeal membrane oxygenation[J].Perfusion,2002,17(6):427-428. 被引量:1

二级参考文献42

  • 1王兴勇,邓华平,柯绍兴.危重病儿血乳酸、血糖检测及其临床意义[J].实用儿科临床杂志,1997,12(1):22-24. 被引量:26
  • 2[1]HillJD, OBrienTG, MurrayJJ, etal. Prolongedextracorporeal oxygenation for acute post - traumatic respiratory failure ( shock - lung syndrome). Use of the Bramson membrane lung[J]. N Engl J Med,1972,286:629 -634. 被引量:1
  • 3[2]Aranki SF, Adams DH, Rizzo RJ, et al. Femoral veno - arterial extracorporeal life support with minimal or no heparin [ J ].Ann Thorac Surg, 1993,56:149 - 155. 被引量:1
  • 4[3]Hogevold HE, Moen O, Fosse E, et al. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro [ J ]. Perfusion,1997,12:9 -20. 被引量:1
  • 5[4]Wendel HP, Scheule AM, Eckstein FS, et al. Haemocompatibility of paediatric membrane oxygenators with heparin - coated surfaces[ J]. Perfusion, 1999,14:21 - 28. 被引量:1
  • 6[5]Korn RL, Fisher CA, Livingston ER, et al. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation[ J]. J Thorac Cardiovasc Surg,1996,111:1073 - 1084. 被引量:1
  • 7[6]Schreurs HH, Wijers MJ, Gu YJ, et al. Heparin - coated bypass circuits: effects on inflammatory response in pediatric cardiac operations[ J]. Ann Thorac Surg,1998,66:166 - 171. 被引量:1
  • 8[7]Moen O, Fosse E, Braten J, et al. Differences in blood activation related to roller/centrifugal pumps and heparin - coated/uncoated surfaces in a cardiopulmonary bypass model circuit[J]. Perfusion,1996,11:113 -123. 被引量:1
  • 9[8]Kaye MP. The registry of the International Society for heart and lung transplantation: Tenth report[ J]. J Heart Lung Transplant, 1993,12:541 - 548. 被引量:1
  • 10[9]Obadia JF, Janier M, Dayoub G, et al. Posttransplant primary heart dysfunction and myocardial stunning[ J]. Journal of Cardiothoracic and Vascular Anesthesia, 1997,11:880 - 882. 被引量:1

共引文献26

同被引文献118

引证文献9

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部